Femtech Market Size By Type (Products, Software, Services), By Application (Reproductive Health, Pregnancy & Nursing Care, Pelvic & Uterine Healthcare, General Healthcare & Wellness), By End-use (Direct-to-consumer, Hospitals, Fertility Clinics, Surgical Centers, Diagnostic Centers), COVID-19 Impact Analysis, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2021– 2027

Published Date: Jul 2021  |  Report ID: GMI4442  |  Authors: Sumant Ugalmugle, Rupali Swain

Report Format: PDF   |   Pages: 120   |   Base Year: 2020




Summary Table of Contents Industry Coverage Methodology

Industry trends

Femtech Market size valued at over USD 22.5 billion in 2020 and is expected to grow at a CAGR of 16.2% from 2021 to 2027. Advancements in service development technologies has improved its potential in basic research and clinical applications. Currently, number of femtech services are available with numerous applications. With effectiveness in disease diagnosis and treatment, the market will witness lucrative growth during the forecast timeframe.
 

Femtech Market

Get more details on this report - Request Free Sample PDF
 

Initiatives taken by government for awareness of women health as well as advanced technological solutions for precise treatment will impel the market expansion. Major healthcare players are emphasizing on creating product pipeline using digital technology. Also, growing companies are majorly investing in R&D to develop innovative products for providing better solutions to women.
 

Rise in burden of lifestyle diseases and access to remote areas regarding women health will foster the market progression

Femtech market has experienced significant positive impact of COVID-19 as several lifestyle diseases affected women health. During pandemic, women faced increasing concern of health conditions such as reproductive disease due to changed lifestyle habits, mental health, high risk of developing metabolic syndrome and other chronic diseases. In pregnancy, mainly miscarriages, stillbirths, and birth complications cases arise that leads into anxiety, depression and hormonal imbalance.
 

Thus, with growing health concerns coupled with restrictive guidelines during the pandemic, industry leaders developed innovative software, services and products with use of digital technology to reach in remote areas across the world. The new generation services provide remote healthcare services to healthcare professionals in hospitals, fertility clinics, diagnostic centers as well as to the patients remotely.
 

Effectivity of advanced products in women health will stimulate product adoption in women healthcare segment

The products segment dominated more than 50% of the femtech market revenue share in 2020. Demand for products owing to high prevalence of chronic and infectious diseases among women for precise diagnostics and treatment spurs the industry growth. Advancements in women health products such as fitness trackers, wearables, exercise products and women hygiene products among others will influence the industry expansion.
 

Innovation through smart medical products is driving the market value. The companies are mainly focusing on development of ground-breaking solutions for female health and wellness. The products assist women health during pregnancy by using technological solutions. Competitive leaders investing in the technology are offering diverse products for major applications.
 

Increasing demand for reproductive health will strengthen the market demand

Global Femtech Market By Type
 

Get more details on this report - Request Free Sample PDF
 

Reproductive health segment captured 24.5% of the femtech market share in 2020 led by the growing awareness regarding reproductive health in majority economies. The services and advanced software enabled-products assist in treatment with several conditions such as sexual and gynaecological health, infections and numerous diseases
 

The industry participants are adopting developmental activities, leading to expansion of offerings and product pipeline for reproductive health of female. Moreover, booming number of new companies that are entering the market are offering various products to manage reproductive health. Along with growing accessibility to feminine products, female population in emerging areas is adopting products for maintaining reproductive health with greater awareness, that will eventually propel the segment growth.
 

Growing patient inflow prone to several diseases will simulate growth potential of diagnostic centers segment

Femtech market demand from diagnostic centers is projected to showcase 16% growth rate through 2027. Diagnostic centers offer various specialty diagnosis options for chronic and infectious diseases.
 

Advent of digital health, especially telehealth solutions, has accelerated patient care process. This has allowed reduction in patient visits, even in the pandemic. Telehealth solutions assist by supporting the patient diagnosis and consultations remotely.
 

Presence of leading companies catering to attractive product demand will continue to strengthen the market growth in the European region

Europe femtech market held over 28% of the revenue share in 2020 on account of the presence of leading industry players with strong product demand in the market. Expansion of manufacturing capacities will further boost product availability and sales. Additionally, increasing number of start-ups in the region will augment the regional growth in the coming years.
 

Product innovations and partnerships to widen offerings are assisting the firms in business expansion

The global femtech market consists of several leaders including HeraMED, Totohealth, Sustain Natural, iSona Health, Minvera, Athena Feminine Technologies, Sera Prognostics, Nuvo, Elvie, Univfy, and Prelude among others. These firms are undertaking several expansion and growth strategies to increase their market presence.
 

Some of the recent industry developments:

  • In September 2020, HeraMED announced Partnership with eCare21, a leading virtual care platform to integrate its heartCARE & heartBEAT products with eCare21 platform. This has enhanced product portfolio and development capabilities of the firm.
  • In August 2019, Grove collaborative acquired Sustain Natural, a leading company in natural sexual wellness products. This strategy fortified the firm’s product portfolio and market position.
     

The femtech market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2016 to 2027 for the following segments:

Market, By Type

  • Products
  • Software
  • Services

Market, By Application

  • Reproductive health
  • Pregnancy & nursing care
  • Pelvic & uterine healthcare
  • General healthcare & wellness
  • Others

Market, By End-use

  • Direct to customer
  • Hospitals
  • Fertility clinics
  • Surgical centers
  • Diagnostic centers
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Russia
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
       

Frequently Asked Questions (FAQ) :

The femtech market is anticipated to cross USD 22.5 billion in 2020 and will strike a CAGR of over 16.2% up to 2027, says this GMI report.
The annual value of the products segment reached over 50% of the market share in 2020 and will grow with the higher prevalence of chronic and infectious diseases in women for precise diagnostics and treatment.
The term femtech refers to products, software and services that use technology to focus on women’s health. It comprises period-tracking apps, fertility solutions, pregnancy & nursing care, reproductive system health, contraception as well as general healthcare and wellness.
The femtech industry share from diagnostic centers is expected to strike a growth rate of 16% through 2027 with the growing need for diverse specialty diagnosis options for chronic and infectious diseases.
Europe held more than 28% of the femtech industry revenue share in 2020 and will witness expansion with the increasing presence of leading industry players and the robust product demand in the region.

Premium Report Details

  • Published Date: Jul 2021
  • Pages: 120
  • Tables: 88
  • Charts / Figures: 12
  • Companies covered: 13
  • Countries covered: 16

Get a report that explains COVID-19 impact on this market

Buy Now

Need a Discount? Get in touch with us for special pricing

Request Discount

 Connect with our sales team

Chat with us
We use cookies to enhance user experience. (Privacy Policy) X